Trading Tips Blog

Lockheed Martin just landed one of the largest single contract awards in company history. On July 29, the Department of War handed the defense giant a seven-year, up to $53.86 billion undefinitized contract action for PAC-3 Missile Segment Enhancement interceptors — pushing the total multiyear deal to $58.62 billion once a prior $4.7 billion award from April is factored in. The scale of the order reflects a stark supply gap: fewer than 800 Patriot missiles reportedly remain in U.S. inventories, ...
Read More About This

Bitcoin miner Riot Platforms just struck a 20-year compute deal with AI firm Anthropic worth $9.1 billion in guaranteed revenue — a figure that could climb to $16.1 billion if the agreement gets extended for two additional five-year terms. The deal leases 191 megawatts of power at Riot's Rockdale, Texas campus, giving Anthropic access to scarce, grid-connected electricity for AI computing. Shares initially spiked more than 20% on the news before giving back almost the entire gain, a reminder that ...
Read More About This

China controls roughly 90% of the world's rare-earth magnet production, and it just showed investors exactly how far it's willing to go to keep that grip. After Washington pushed to build a rare earth supply chain outside Beijing's control, China's Ministry of Commerce added several U.S. companies to its export-control blacklist this past June. MP Materials, the only U.S. company that can mine, refine, and manufacture rare earths into finished magnets at commercial scale, was directly in the crosshairs — ...
Read More About This

The weight-loss drug wars just went international. Eli Lilly won UK approval for its oral GLP-1 pill Foundayo (orforglipron) on Monday, its first green light outside the United States, setting up a direct clash with Novo Nordisk's Wegovy pill in one of the world's most closely watched pharmaceutical markets. It's only the second oral weight-loss pill approved in Europe, arriving just two months after Novo's version launched there.The competitive dynamics are worth tracking closely. Foundayo launched in the U.S. back ...
Read More About This

Wall Street's bulls just got more ammunition. JPMorgan raised its year-end S&P 500 target to 8,000 on Monday, up from 7,800, arguing that this earnings season has finally proven the AI spending boom is paying off rather than just burning cash. The new target implies roughly 3% more upside from Friday's close of 7,757.64 — modest on paper, but notable because it comes from one of the Street's most closely watched strategists.The earnings data backing this call is striking. With ...
Read More About This

Intel just made its boldest capital move of the year. The chipmaker upsized its stock offering to $20 billion at $95 per share on Tuesday, a sharp jump from the $15 billion raise it announced just one day earlier. The move signals just how fast demand for AI computing power is outpacing even aggressive spending plans, and it comes as Intel tries to cement its comeback in the semiconductor race.The numbers tell the story. Intel expects to net $19.7 billion ...
Read More About This

Energy stocks caught a fresh bid Monday as hopes for reopening the Strait of Hormuz faded, pushing crude oil prices sharply higher and reversing last week's brief relief rally. Brent crude futures jumped 3.3% to $84.64 a barrel, while U.S. West Texas Intermediate climbed 3.1% to $80.63, as Iran continued to demand an end to military threats, sanctions relief, and compensation before agreeing to reopen the critical waterway. The renewed uncertainty erased much of last week's seven percent pullback in ...
Read More About This

Taiwan Semiconductor Manufacturing just delivered the clearest proof yet that AI chip demand isn't cooling off, even as investors have grown nervous about the sustainability of the artificial intelligence spending boom. The world's largest contract chipmaker reported July revenue of 467.58 billion New Taiwan dollars, roughly $14.5 billion, up 44.7% from a year earlier. That pace puts TSMC ahead of its own full-year guidance of roughly 40% revenue growth, a rare case of a bellwether company outrunning its own bullish ...
Read More About This